Â鶹Éç

Available for over a year

Eli Lilly, which makes donanemab, says it slows the pace of Alzheimer's by about a third. Dr Liz Coulthard, is an Associate Professor in Dementia Neurology at the University of Bristol. Newshour's Julian Marshall asked her how the new drug works and how it could impact the treatment of Alzheimer's in the future.